Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Trulieve to Transition to Domestic Issuer Status in United States Effective January 1, 2021

C.TRUL

TALLAHASSEE, Fla., July 14, 2020 /CNW/ - Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) ("Trulieve" or "the Company"), a leading and top-performing cannabis company based in the United States, today announced that since more than 50% of the Company's issued and outstanding subordinate voting shares were directly or indirectly owned by shareholders of record domiciled in the United States on June 30, 2020, Trulieve no longer meets the definition of a "foreign private issuer" under United States securities laws.

Trulieve Cannabis Corp. Logo (CNW Group/Trulieve Cannabis Corp.)

As a result, the Company will be deemed a U.S. domestic issuer under United States securities laws and will be subject to SEC reporting requirements applicable to U.S. domestic companies no later than January 1, 2021. These U.S. reporting requirements will require Trulieve's financial statements and financial data to be presented under U.S. GAAP. Trulieve anticipated this reporting change and has an established task force of internal and external resources in place to manage the transition.

Although the Company will become a U.S. registrant with the SEC, it will continue to be a British Columbia corporation. Other than officers, directors and 5% or more owners, Trulieve's shareholders are not required to take any action as a result of the Company's transition to U.S. domestic issuer status. Trulieve's subordinate voting shares, warrants and 9.75% senior secured notes will continue to be listed on the Canadian Securities Exchange under the symbol "TRUL", "TRUL.WT" and "TRUL.DB.U", respectively.

About Trulieve
Trulieve is a vertically integrated "seed-to-sale" company and is the first and largest fully licensed medical cannabis company in the State of Florida. Trulieve cultivates and produces all of its products in-house and distributes those products to Trulieve-branded stores (dispensaries) throughout the State of Florida, as well as directly to patients via home delivery. Trulieve also operates in California, Massachusetts, and Connecticut. Trulieve's subordinate voting shares are listed on the Canadian Securities Exchange under the symbol "TRUL" and trade on the OTCQX market under the symbol "TCNNF".

To learn more about Trulieve, visit www.Trulieve.com.

SOURCE Trulieve Cannabis Corp.

Cision View original content to download multimedia: http://www.newswire.ca/en/releases/archive/July2020/14/c4450.html

Lynn Ricci, Director of Investor Relations, (850) 480-7955, IR@trulieve.comCopyright CNW Group 2020



Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today